C
RNAC
Cartesian
5.98
-0.20-3.24%After Hours: 5.98 0.00 0.00%16:10 04/10 EDT
OPEN/PREV CLOSE6.19/6.18
TODAY RANGE5.82-6.31
VOL174.87K
MARKET CAP158.52M
52 WEEK RANGE5.60-15.57
AVG VOL (3M)176.53K
% TURNOVER0.66%
TURNOVER--
P/E (TTM)-1.1920
% RANGE7.36%
EPS(TTM)-5.0168
P/E(FORWARD)-1.6989
P/B-1.2322
BVPS-4.8533
DIVIDEND--
P/S55.63
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP63.88M
SHARES OUTSTANDING26.51M
NEXT EARNINGS05/06-05/11
FREE FLOAT10.68M
LOT SIZE1
EX-DATE04/05/2024
News
Press Releases
Financial Reports
Profile
TipRanks·03/30 22:46
Cartesian Therapeutics Announces Board Member Murat Kalayoglu Resignation
Reuters·03/30 21:48
Cartesian Therapeutics director Murat Kalayoglu resigns, effective March 31
TipRanks·03/10 13:05
Wedbush Reaffirms Their Buy Rating on Cartesian Therapeutics (RNAC)
Dow Jones·03/10 12:33
Cartesian Therapeutics Price Target Maintained With a $38.00/Share by Wedbush
NASDAQ·03/10 00:03
Cantor Fitzgerald Upgrades Cartesian Therapeutics (RNAC)
Dow Jones·03/09 17:51
Cartesian Therapeutics Stock Gains on Full-Year Revenue Beat
Dow Jones·03/09 17:04
Cartesian Therapeutics Raised to Overweight From Neutral by Cantor Fitzgerald
Dow Jones·03/09 17:04
Cartesian Therapeutics Price Target Announced at $16.00/Share by Cantor Fitzgerald
Same Industry